1. Home
  2. FDMT vs AWF Comparison

FDMT vs AWF Comparison

Compare FDMT & AWF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo 4D Molecular Therapeutics Inc.

FDMT

4D Molecular Therapeutics Inc.

N/A

Current Price

$10.21

Market Cap

695.3M

Sector

Health Care

ML Signal

N/A

Logo Alliancebernstein Global High Income Fund

AWF

Alliancebernstein Global High Income Fund

N/A

Current Price

$9.46

Market Cap

819.2M

Sector

Finance

ML Signal

N/A

Company Overview

Basic Information
Metric
FDMT
AWF
Founded
2013
1993
Country
United States
United States
Employees
N/A
31
Industry
Biotechnology: Pharmaceutical Preparations
Trusts Except Educational Religious and Charitable
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
695.3M
819.2M
IPO Year
2019
N/A

Fundamental Metrics

Financial Performance
Metric
FDMT
AWF
Price
$10.21
$9.46
Analyst Decision
Strong Buy
Analyst Count
12
0
Target Price
★ $28.09
N/A
AVG Volume (30 Days)
★ 855.5K
435.6K
Earning Date
11-12-2026
01-01-0001
Dividend Yield
N/A
★ 7.57%
EPS Growth
★ 18.79
N/A
EPS
N/A
★ N/A
Revenue
★ $85,209,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$20.79
N/A
P/E Ratio
★ N/A
N/A
Revenue Growth
★ 230194.60
N/A
52 Week Low
$6.96
$9.40
52 Week High
$16.93
$10.87

Technical Indicators

Market Signals
Indicator
FDMT
AWF
Relative Strength Index (RSI) 37.51 41.00
Support Level $8.43 $9.42
Resistance Level $10.61 $10.24
Average True Range (ATR) 0.85 0.08
MACD -0.15 -0.02
Stochastic Oscillator 1.07 17.11

Price Performance

Historical Comparison
FDMT
AWF

About FDMT 4D Molecular Therapeutics Inc.

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

About AWF Alliancebernstein Global High Income Fund

Alliancebernstein Glb High Inc Fund Inc is a United States-based diversified, closed-end management investment company. Its primary investment objective is to seek high current income, and secondarily, capital appreciation. The fund invests in debt securities, including Sovereign Debt Obligations and corporate debt, denominated in non-U.S. currencies as well as in the U.S. Dollar. It may invest without limit in emerging and developed markets and debt securities of U.S. and non-U.S. corporate issuers.

Share on Social Networks: